Skip to main content
. 2004 Feb 24;90(6):1144–1150. doi: 10.1038/sj.bjc.6601655

Table 2. Needs and preferences during the follow-up visits (%).

  Not important/do not want this (%) Not very important/do not care (%) Very important/I certainly want this (%)
General topics      
How much would you like the following topics to be part of the follow-up visit?
 Information on the long-term effects of treatment 2.5 13.50 84.00
 Information on own prognosis 6.3 8.9 84.80
 Information on life rules after a diagnosis of breast cancer (e.g. nutrition) 7.5 26.30 66.30
 Information on side effects of treatment 3.7 9.9 86.40
 Additional investigations (e.g. X-ray and blood tests) 6.6 11.80 81.60
 
Specific topics      
In how far you would like to talk about the following subjects during the follow-up visits?
 Prevention of breast cancer 13.20 14.50 72.40
 Heredity factors 18.40 13.20 68.40
 Changes in the untreated breast 20.20 14.90 64.90
 Feeling fatigued 25.00 22.40 52.60
 Pain (e.g. nerve pain) 26.00 27.40 46.60
 Fear 38.20 21.10 40.70
 Nutrition 37.80 35.10 27.10
 Use of OACs or HRTsa 39.10 11.60 49.30
 Breast reconstruction (if applicable) 50.00 24.20 25.80
 Acceptation by family and friends 52.80 27.80 19.40
 
How much you would like the following topics to be part of the follow-up visit?
 Information on breast cancer self-help groups 40.50 40.50 19.00
 Consultation with psychologist or psychiatrist 53.80 38.50 7.7
 Consultation with hospital social worker 44.30 39.20 16.50
 Consultation with pastoral care provider 59.00 34.60 6.4
 
Organisation Every year (%) Every 6 months (%) Every 3 months (%)
How often would you prefer to attend routine control visits? 16.20 58.80 25.00
  5 years (%) 10 years (%) Lifelong (%)
 
For how long would you prefer to attend routine control visits? 12.10 22.00 65.90
 
  General practitioner (%) Specialised nurse (%) Hospital doctor (%)
By whom should the follow-up be performed? 7.60 6.30 86.10
a

OA=oral anticonceptiva; HRT=hormone replacement therapy.